- Newsletter
- April 2024
Global
From €1010EUR$1,119USD£898GBP
- Report
- January 2022
- 419 Pages
Global
From €9184EUR$9,500USD£7,894GBP
- Report
- November 2021
- 101 Pages
Global
From €4350EUR$4,500USD£3,739GBP
- Report
- May 2021
- 50 Pages
China
From €2513EUR$2,600USD£2,160GBP
Seretide is a brand of respiratory drug used to treat asthma and chronic obstructive pulmonary disease (COPD). It is a combination of two active ingredients, fluticasone propionate and salmeterol, which work together to reduce inflammation and open up the airways. It is available in both inhaler and dry powder inhaler forms.
Seretide is a widely used drug in the respiratory market, with its combination of two active ingredients providing a more effective treatment than either ingredient alone. It is used to treat both acute and chronic symptoms of asthma and COPD, and is suitable for both adults and children.
The respiratory drug market is highly competitive, with many different brands and formulations available. Companies in the market include GlaxoSmithKline, AstraZeneca, Boehringer Ingelheim, Merck & Co., and Novartis. Show Less Read more